Serial Number
85419182
Owner
TAKEDA PHARMACEUTICALS U.S.A., INC.Attorney
Karl M. Zielaznicki, Esq.First Use Date
Mar 30, 2012
Filing Date
Sep 9, 2011
TUMMY TRENDS Trademark
Serial Number: 85419182 • Registration: 4621478
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
500 Kendall Street
Cambridge, MA 02142
Entity Type: 03
ONE TAKEDA PARKWAY
DEERFIELD,, IL 60015
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
September 9, 2011
Registration Date
October 14, 2014
First Use Anywhere
March 30, 2012
First Use in Commerce
March 30, 2012
Published for Opposition
March 19, 2013
Cancellation Date
May 21, 2021
Goods & Services
educational services, namely, providing tutorials in chronic constipation and irritable bowel syndrome and distribution of reports, reminders, interactive graphs displaying and comparing a user's personal health records therewith
Computer application software for mobile phones, portable media players, handheld computers and personal computers, namely, software for providing information about personal activities that may impact, constipation and irritable bowel syndrome with healthcare providers, namely, severity of symptoms, medications and treatments, stress levels, exercise, fiber intake, water intake, stool form and appearance, days traveling, habits that may help improve symptoms and topics they may wish to discuss with their physician, and providing educational information about constipation and irritable bowel syndrome
Providing internet-based healthcare information; providing online information regarding constipation and irritable bowel syndrome; providing information regarding constipation; providing information to a doctor regarding a patient's data relating to chronic constipation and irritable bowel syndrome via e-mail
